Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Debt Ratio (2016 - 2025)

Avalo Therapeutics (AVTX) has disclosed Debt Ratio for 11 consecutive years, with 0.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Debt Ratio changed N/A year-over-year to 0.0, compared with a TTM value of 0.0 through Jun 2025, changed N/A, and an annual FY2024 reading of 0.0, changed N/A over the prior year.
  • Debt Ratio was 0.0 for Q2 2025 at Avalo Therapeutics, up from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.58 in Q2 2022 and bottomed at 0.0 in Q4 2024.
  • Average Debt Ratio over 5 years is 0.27, with a median of 0.35 recorded in 2022.
  • Peak annual rise in Debt Ratio hit 1.26% in 2022, while the deepest fall reached 1.26% in 2022.
  • Year by year, Debt Ratio stood at 0.41 in 2021, then fell by 1.26% to 0.4 in 2022, then dropped by 28.51% to 0.29 in 2023, then plummeted by 99.17% to 0.0 in 2024, then rose by 22.39% to 0.0 in 2025.
  • Business Quant data shows Debt Ratio for AVTX at 0.0 in Q2 2025, 0.0 in Q1 2025, and 0.0 in Q4 2024.